THE HEALTH | DECEMBER , 2023

BY KHIRTINI K KUMARAN

“ Since the launch of the first disposable contact lens in 1987 , J & J Vision has maintained a commitment to keeping patients and eye care professionals ( ECPs ) at the core of its mission ,” said J & J Vision Head of R & D Asia-Pacific and Japan , Biten Kathrani .

Understanding the patient and wearer journey and the challenges faced by eye care practitioners ( ECPs ) are foundational to J & J Vision ’ s innovation . J & J Vision ’ s unwavering focus on patient-centric technology and continuous innovation underscores its commitment to addressing the diverse eye health needs of individuals across the globe , particularly in the Asia Pacific and Japan region .

INTEGRATING PATIENT-CENTRIC TECHNOLOGY

The insights and understandings are translated into unmet needs , forming the basis for technical problem statements , explained Kathrani .

“ This is where our research and development ( R & D ) and innovation engine thrives . We challenge the status quo to incubate and develop new products .

“ This includes investments in materials , optics design , and manufacturing technologies to ensure consistent , innovative contact lenses solutions . Then , we serve the consumers and the ECPs with these technologies .

“ All the while , we make sure that we are keeping the core value of the ACUVUE ® brand central , which is to deliver superior

Biten Kathrani

J & J Vision recognises the diverse requirements across the lifetime journey , from pediatric to mature eyes . The region is expected to have 1.3 billion people above 60 by 2050 , and childhood myopia is a prevalent concern .” – Biten Kathrani

vision combined with eye health in the form of comfort and safety , and also taking care of the evolving and changing lifestyle needs of consumers .”

NURTURING INNOVATION FOR GLOBAL EYE HEALTH

J & J Vision ’ s commitment extends globally , with cross-functional teams of professionals dedicated to innovating new technologies . “ We have a world-class team of R & D professionals around the world , comprising scientists , engineers , clinicians , and biostatisticians , who thrive on innovating new technologies and making sure J & J Vision lives up to its Vision Made Possible aspiration for every patient , at every age , in every stage of life and in every corner of the world .”

“ Apart from our R & D teams , we ’ ve also developed strong collaborations with clinical and research centres of excellence worldwide , including in the Asia Pacific region , to ensure a global perspective in driving scientific advancements .”

The Asia Pacific and Japan regions , representing over 50 per cent of the world ’ s population , pose significant eye health needs with an estimated eight billion eyes to serve , shared Kathrani .

“ J & J Vision recognises the diverse requirements across the lifetime journey , from pediatric to mature eyes . The region is expected to have 1.3 billion people above 60 by 2050 , and childhood myopia is a prevalent concern .”

J & J Vision focuses on delivering innovations tailored to each stage of life , addressing needs such as myopia management for pediatric eyes , personalised vision correction and ocular surface health for adult eyes via contact lenses and refractive laser surgery , and presbyopia and cataract solutions for aging eyes .

“ The goal is to provide superior vision , all-day comfort , safety , and additional benefits like therapeutics , cosmesis and light management .”

COLLECTIVE COMMITMENT AND DEDICATION

He expressed enthusiasm about the Johnson & Johnson Institute Symposium : Revolutionising Patient Eye Care & Management , where more than 300 participants showed keen interest in the evolving technologies .

Kathrani presented on ‘ Revolutionising Eye Health via Patient Centric Technology & Innovation ’.

The symposium showcased J & J Vision ’ s dedication to meeting consumer and ECP needs . Partners actively participated , highlighting the collective commitment to revolutionising patient eye care and management beyond 2023 . – The Health